These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37108853)

  • 21. The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.
    Zhang S; Wang S; Wan Z; Li R; Yu J
    Biomed Res Int; 2015; 2015():943691. PubMed ID: 25685819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis.
    Lai G; Zeng C; Mo J; Song WD; Xu P
    J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31941687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspergillus Lateral Flow Assay with Digital Reader for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis (CAPA): a Multicenter Study.
    Autier B; Prattes J; White PL; Valerio M; Machado M; Price J; Egger M; Gangneux JP; Hoenigl M
    J Clin Microbiol; 2022 Jan; 60(1):e0168921. PubMed ID: 34643415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchoalveolar lavage fluid and serum 1,3-β-D-glucan testing for invasive pulmonary aspergillosis diagnosis in hematological patients: the role of factors affecting assay performance.
    Weinbergerova B; Kabut T; Kocmanova I; Lengerova M; Pospisil Z; Kral Z; Mayer J
    Sci Rep; 2020 Oct; 10(1):17963. PubMed ID: 33087853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
    Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
    J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
    Urabe N; Sakamoto S; Sano G; Suzuki J; Hebisawa A; Nakamura Y; Koyama K; Ishii Y; Tateda K; Homma S
    J Clin Microbiol; 2017 Jun; 55(6):1738-1746. PubMed ID: 28330887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
    Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?
    Dellière S; Dudoignon E; Voicu S; Collet M; Fodil S; Plaud B; Chousterman B; Bretagne S; Azoulay E; Mebazaa A; Dépret F; Mégarbane B; Alanio A
    J Clin Microbiol; 2022 Mar; 60(3):e0216921. PubMed ID: 34985983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
    Aydoğan S; Kuştimur S; Kalkancı A
    Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
    Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
    Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?
    Caggiano G; Apollonio F; Consiglio M; Gasparre V; Trerotoli P; Diella G; Lopuzzo M; Triggiano F; Stolfa S; Mosca A; Montagna MT
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspergillus infection and extracorporeal membrane oxygenation support.
    Garcia X; Mian A; Mendiratta P; Gupta P; Rycus P; Prodhan P
    J Intensive Care Med; 2013; 28(3):178-84. PubMed ID: 22328597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.
    Boch T; Reinwald M; Spiess B; Liebregts T; Schellongowski P; Meybohm P; Rath PM; Steinmann J; Trinkmann F; Britsch S; Michels JD; Jabbour C; Hofmann WK; Buchheidt D
    J Crit Care; 2018 Oct; 47():198-203. PubMed ID: 30015290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of galactomannan antigen in the bronchial washing and serum for diagnosing pulmonary aspergillosis.
    Kono Y; Tsushima K; Yamaguchi K; Kurita N; Soeda S; Fujiwara A; Sugiyama S; Togashi Y; Kasagi S; To M; To Y; Setoguchi Y
    Respir Med; 2013 Jul; 107(7):1094-100. PubMed ID: 23632100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Utility of Galactomannan and Polymerase Chain Reaction Assays in Bronchoalveolar Lavage for Diagnosis of Chronic Pulmonary Aspergillosis.
    Chowdhury M; Singh G; Pandey M; Mishra H; Meena VP; Sethi P; Singh A; Prakash B; Upadhyay AD; Mohan A; Sinha S; Xess I; Wig N; Kabra SK; Ray A
    Mycopathologia; 2023 Dec; 188(6):1041-1053. PubMed ID: 37857979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Sōna Aspergillus Galactomannan LFA with digital readout as diagnostic and as screening tool of COVID-19 associated pulmonary aspergillosis in critically ill patients. Data from a multicenter prospective study performed in Argentina.
    Giusiano G; Fernández NB; Vitale RG; Alvarez C; Ochiuzzi ME; Santiso G; Cabeza MS; Tracogna F; Farías L; Afeltra J; Noblega LM; Giuliano CV; Garcia-Effron G
    Med Mycol; 2022 May; 60(5):. PubMed ID: 35394043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity.
    Machado M; Valerio M; Álvarez-Uría A; Olmedo M; Veintimilla C; Padilla B; De la Villa S; Guinea J; Escribano P; Ruiz-Serrano MJ; Reigadas E; Alonso R; Guerrero JE; Hortal J; Bouza E; Muñoz P;
    Mycoses; 2021 Feb; 64(2):132-143. PubMed ID: 33210776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.